Liver Cancer/HCC
Liver Cancer/HCC
Gene Variation Linked to Liver Cancer in Hepatitis C Patients
- Details
- Category: Liver Cancer/HCC
- Published on Friday, 08 July 2011 12:38
- Written by HIVandHepatitis.com
A genome-wide association study looking at more than 460,000 single nucleotide changes found that a variation in the DEPDC5 gene on chromosome 22 is associated with increased risk of hepatocellular carcinoma in people with hepatitis C.
Screening for Liver Cancer in HIV/HCV Coinfected People
- Details
- Category: Liver Cancer/HCC
- Published on Friday, 28 May 2010 23:40
- Written by Liz Highleyman
Nearly half of HIV/HCV coinfected individuals with liver cancer in an international study were never screened for hepatocellular carcinoma, but those who did undergo screening had their cancer detected at an earlier stage, leading to more effective treatment and improved survival, according to a report presented at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010) last month in Vienna.
A Small Proportion of Hepatitis C Patients Develop Liver Cancer despite Sustained Response to Interferon-based Therapy
- Details
- Category: HCV Treatment
- Published on Tuesday, 14 April 2009 14:01
- Written by Liz Highleyman
Over years or decades, chronic hepatitis C virus (HCV) infection can lead to advanced liver disease, including cirrhosis and hepatocellular carcinoma (HCC). Sustained response to interferon-based therapy dramatically reduces the risk of liver disease progression, but does not eliminate it completely, according to 2 recently published studies.
Chronic Hepatitis C Complications are Increasing, Especially among People Older than 60 Years
- Details
- Category: HCV Disease Progression
- Published on Tuesday, 30 March 2010 14:02
- Written by Liz Highleyman
The proportion of people with chronic hepatitis C virus (HCV) infection who will develop advanced liver disease including cirrhosis, decompensation, and liver cancer is likely to increase over the next 10-20 years as people infected decades ago reach the stage of developing advanced disease; these complications are expected to be especially common among people over age 60. But more widespread treatment could significantly lower projected rates of disease progression, according to a study published in the February 2010 issue of Gastroenterology.
Two Studies Look at Promising Therapies for Liver Cancer: Sorafenib and Doxorubicin
- Details
- Category: Liver Cancer/HCC
- Published on Friday, 25 July 2008 00:00
- Written by Liz Highleyman
Two recently published studies produced promising data on experimental therapies for HCC: the systemic chemotherapy drug sorafenib (Nexavar), and combination therapy using doxorubicin-eluting beads plus radiofrequency ablation.
Web Design and Development by